Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$534.64 USD

534.64
645,982

+2.78 (0.52%)

Updated Jul 10, 2024 01:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher (TMO) to Buy Patheon, Expand in Biopharma

Thermo Fisher Scientific Inc. (TMO), a leading scientific instrument maker, recently agreed to acquire Netherlands-based Patheon N.V.

    Thermo Fisher (TMO) Tops Q1 Earnings, Sales, Raises Guidance

    Thermo Fisher Scientific, Inc. (TMO) reported better-than-expected first-quarter 2017 earnings results.

      Thermo Fisher (TMO) Beats on Q1 Earnings & Sales Estimates

      Currently, Thermo Fisher has a Zacks Rank #3 (Hold) but that could change following its promising first-quarter 2017 earnings report which has just released.

        Thermo Fisher (TMO) Up 4.5% Since Earnings Report: Can It Continue?

        Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

          Will Thermo Fisher (TMO) Pull a Surprise in Q1 Earnings?

          Thermo Fisher Scientific, Inc. (TMO) is scheduled to report first-quarter 2017 results before the opening bell on Apr 26.

            Should Value Investors Consider Thermo Fisher (TMO) Stock?

            Let's see if Thermo Fisher Scientific, Inc. (TMO) stock is a good choice for value-oriented investors right now from multiple angles.

              Sweta Killa headshot

              Trump, Biogen and Amgen Hammer Healthcare ETFs

              After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

                Thermo Fisher Poised on Innovation, Global Growth Amid Woes

                On Mar 17, 2017, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).

                  The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines

                  The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines

                    Mark Vickery headshot

                    Top Research Reports for February 1, 2017

                    Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), PayPal (PYPL) and Thermo Fisher (TMO).

                      Thermo Fisher (TMO) Q4 Earnings Beat, Organic Sales Flat

                      Thermo Fisher Scientific, Inc. (TMO) reported better-than-expected fourth-quarter and full-year 2016 earnings results.

                        Thermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues

                        Thermo Fisher (TMO) has posted earnings which has beaten the Zacks Consensus Estimate but its revenues missed the mark.

                          Tracey Ryniec headshot

                          4 Stocks with Great Earnings Charts

                          Companies that beat nearly every quarter are earnings all-stars.

                            Medical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC

                            Let's take a look at the major Medical Product stocks slated to release their earnings results on tomorrow.

                              Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?

                              Thermo Fisher Scientific, Inc. (TMO) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Jan 31.

                                Mark Vickery headshot

                                Top Research Reports for January 12, 2017

                                Today's Research Daily features new research reports on 16 major stocks, including Goldman Sachs (GS), Canadian National Railway (CNI) and Boeing (BA).

                                  5 GARP Stocks that Should Grace Your Portfolio

                                  Growth at a reasonable price or GARP is speculated to offer investors a chance to get hold of stocks that are undervalued but have impressive growth potential.

                                    The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding

                                    The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding

                                      Sheraz Mian headshot

                                      Postive Bank Results This Earnings Season

                                      Plenty of results are still to come, but the big banks are showing a notable improvement in their earnings power.

                                        Sheraz Mian headshot

                                        New Research Reports for Tesla, Exxon, JNJ & Others

                                        Today's must-read reports are for Exxon Mobil (XOM), Johnson & Johnson (JNJ) and Tesla (TSLA).

                                          Sheraz Mian headshot

                                          Top 7 Research Reports for July 29, 2016

                                          Today's must-read reports are for Amgen (AMGN), JPMorgan (JPM) and Mondelez (MDLZ).

                                            4 Medical Instrument Stocks to Bet on This Earnings Season

                                            The medical instrument sector holds a lot of promise at this moment.

                                              Rush in Medical Device Investments: Should You Buy These Stocks?

                                              Coming to the weakest links in the MedTech sector, we advise investors against names that offer little growth/opportunity in the near term.

                                                Should You Buy Evolving Trends in Medical Devices?

                                                Given the U.S. government's pushback on tax-dodging, we expected some sloth to creep into the medical device space as far as M&As are concerned. But to our surprise, M&A activity worldwide has remained fairly stable.